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Abstract
Background: Intake of red meat is considered a risk factor for colorectal cancer (CRC) development, and heme, the
prosthetic group of myoglobin, has been suggested as a potential cause. One of the proposed molecular mechanisms
of heme-induced CRC is based on an increase in the rate of lipid peroxidation catalysed by heme.
Methods: In the present work, the novel A/J Min/+ mouse model for Apc-driven colorectal cancer was used to
investigate the effect of dietary heme (0.5 μmol/g), combined with high (40 energy %) or low (10 energy %) dietary
fat levels, on intestinal carcinogenesis. At the end of the dietary intervention period (week 3–11), spontaneously
developed lesions in the colon (flat aberrant crypt foci (flat ACF) and tumors) and small intestine (tumors) were scored
and thiobarbituric reactive substances (TBARS), a biomarker for lipid peroxidation was analysed in feces.
Results: Dietary hemin significantly reduced colonic carcinogenesis. The inhibitory effect of hemin was not dependent
on the dietary fat level, and no association could be established between colonic carcinogenesis and the lipid
oxidation rate measured as fecal TBARS. Small intestinal carcinogenesis was not affected by hemin. Fat tended to
stimulate intestinal carcinogenesis.
Conclusions: Contradicting the hypothesis, dietary hemin did inhibit colonic carcinogenesis in the present study. The
results indicate that fecal TBARS concentration is not directly related to intestinal lesions and is therefore not a suitable
biomarker for CRC.
Keywords: Colorectal cancer, Intestinal carcinogenesis, Red meat, Heme iron, Min mouse model, Lipid peroxidation,
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Background
Globally, colorectal cancer (CRC) is the third most
frequent form of cancer in men and the second most
frequent in women. More than half of all CRC cases re-
corded in 2012 occurred in developed countries [1].
Therefore, an association between western lifestyle fac-
tors and incidence of CRC has been suggested. In 2007,
the World Cancer Research Fund considered intake of
red and processed meat to be a convincing risk factor
for CRC [2], and in 2015 the International Agency for
Research on Cancer (IARC) classified processed meat
carcinogenic to humans (Group 1) and red meat as
probably carcinogenic to humans (Group 2A) [3]. Even
though several experimental studies in rodents have
suggested a relationship between red meat intake and
CRC [4–6], the role of red meat in initiation, promo-
tion and progression of CRC is not clarified. Interest-
ingly, animal studies were not able to reproduce
epidemiological findings until basal diets were modified
to reflect a “Western style diet” characterized by high
fat, low calcium, and low antioxidants [7, 8], indicating
complex mechanisms of action. Potential mechanisms
involving heme iron, the red pigment in meat, seem
promising, as these may explain why red meat, but not
white meat (low in heme iron) is associated with CRC
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[9, 10]. Dietary heme iron (hemin) was found to cause
similar colonic changes as meat-based diets in
azoxymethane-treated rats [11], and changes in gene
expression linked to cancer and proliferation were de-
tected in colon scrapings of mice after only 4 days of
heme iron (hemin) administration [12]. Two main hy-
potheses connect heme iron to CRC: its catalytic effect
on peroxidation of lipids and its catalytic effect on the
formation of N-nitrosamines (NOCs). Many lipid peroxi-
dation products, including thiobarbituric reactive sub-
stances (TBARS) like malondialdehyde, as well as NOCs
are potentially cytotoxic and mutagenic [4, 9, 10, 13].
Fat is susceptible to lipid peroxidation, and TBARS, a
biomarker for lipid peroxidation, have repeatedly been
linked to heme-induced tumor promotion [14, 15]. It
has previously been suggested that reactive lipid perox-
ides may be covalently added to the protoporphyrin ring
of heme, which may result in the formation of a cyto-
toxic heme factor (CHF) [12, 16]. As lipid peroxidation
was found to occur before cytotoxicity, it was hypothe-
sized that peroxidation products need to accumulate
before the CHF forms [12].
Germline mutations in the tumor-suppressor gene
adenomatous polyposis coli (APC) causes familial aden-
omatous polyposis (FAP), an inherited colorectal cancer
syndrome. Similarly, the multiple intestinal neoplasia
(Min/+) mouse, which is heterozygous for a truncation
mutation at codon 850 of Apc, develops multiple spon-
taneous intestinal lesions. Apc controls the proliferation
[17], apoptosis [18] migration and differentiation [19] of
enterocytes by interfering with the Wnt signaling path-
way. Complete somatic inactivation of APC/Apc in
discrete crypts of the intestinal epithelium appears to be
the initial carcinogenic event in Min/+ mice, human
FAP and the majority of sporadic colorectal cancer in
humans [20]. The Min/+ mouse model is frequently
used to study factors that may influence critical events
in Apc-driven intestinal carcinogenesis. However, in con-
trast to human FAP, conventional C57BL/6 J Min/+ mice
develop tumors predominantly in the small intestine
[21–24]. Recently, a novel Min/+ mouse on an A/J gen-
etic background was suggested to provide a better model
for colon cancer, as these mice also develop numerous
adenomas in the colon that eventually progress to car-
cinomas in old individuals [25]. Furthermore, this novel
A/J Min/+ mouse model demonstrated a continuous de-
velopmental growth of colonic lesions highlighted by the
transition of early lesions, flat aberrant crypt foci (flat
ACF), to tumors over time.
Recently, the A/J Min/+ mouse model was used to test
the effect of dietary hemin, either alone or in combin-
ation with nitrite on intestinal carcinogenesis [26]. Sur-
prisingly, dietary hemin was found to suppress the
development of colonic lesions, independently of the
presence of nitrite, and it was speculated whether the
lack of the expected stimulation could be related to the
low level of fat (4 %) in the AIN-93 M diet. Sesink et al.
[27] observed enhanced the heme-induced cytolytic
activity of colonic content as well as a greater rate of
epithelial proliferation in rat colons with increasing diet-
ary fat level. Therefore, the present study aimed to in-
vestigate the effects of heme in the A/J Min/+ mouse
model when fat levels were taken into account. Beef tal-
low was chosen as the fat source to reflect the fatty acid
composition of red meat.
The aim of the present study was to: i) examine the ef-
fect of dietary heme on intestinal carcinogenesis in A/J
Min/+ mice fed a low or high fat diet; ii) examine
whether intestinal carcinogenesis is related to the pro-
duction of fecal TBARS.
Methods
Animals
The experiment was approved by the Norwegian Animal
Research Authority (application ID: 6704) and con-
ducted in compliance with local and national regulations
on animal experimentation. The animals were main-
tained in open top plastic cages on a 12-h light/dark
cycle at 20–22 °C and 55–56 % humidity. Weight gain
was monitored once every 2 weeks during the experi-
ment. Animals were sacrificed by cervical dislocation.
The A/J Min/+ mouse model was developed at the
Norwegian Institute of Public Health [28], and later
transferred, and subsequently maintained, at the experi-
mental animal facility at the Norwegian University of
Life Science, Campus Adamstuen. For breeding, two
female A/J wild-type mice were placed together with one
male A/J Min/+ mouse. On day 19–21 after birth, off-
spring were weaned and randomly assigned to the
experimental diets, being allowed free access to diet and
water. As only A/J Min/+ mice were included in the ex-
periment, DNA was extracted from ear punch samples
and subjected to allele-specific PCR for determination of
the genotype. The following primer set was used for
DNA amplification: MAPC MT (5’-TGAGAAAGACAG
AAGTTA -3’), MAPC 15 (5’-TTCCACTTTGGCATAA
GGC-3’), and MAPC 9 (5’-GCCATCCCTT- CACGTT
AG-3’). The PCR product of a wild-type allele consists
of 618 bp and is visible as a band for both wild type
(+/+) and Min/+ mice. In the presence of the Min allele,
an additional PCR product of 327 bp is generated [29].
Diets and study design
From weaning at 3 weeks until termination at 11 weeks,
the A/J Min/+ mice were fed four different experimental
diets (Table 1): Hemin−, Low fat (low fat control with no
hemin); Hemin+, Low fat (low fat with hemin); Hemin−,
High fat (high fat control with no hemin); Hemin+, High
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fat (high fat with hemin). Beef tallow was used as a fat
source, providing 10 % (low fat diet) and 40 % (high fat
diet) of the energy. The number of animals per study
group is indicated in Table 1. Based on the assumption
that the total daily caloric intake would be equivalent
between the low fat and high fat groups, high fat diets
were formulated on an isocaloric exchange basis to com-
pensate for the increase in energy density in the high fat di-
ets. After balancing, all diets contained corresponding
amounts of nutrients per megajoule. Heme was added in
the form of hemin, a protoporhyrin IX with a chloride lig-
and associated with the central, ferric iron ion. All diets
were customized to be deficient in calcium (0.08/0.10 % in
low and high fat diet, respectively) and vitamin D3, as these
are natural protectants against CRC development [30].
Vitamin D3 was removed from the vitamin mix, and
vitamin D3 level in casein was confirmed to be <100 iu/kg.
Hence, the low fat and high fat diet contained no more
than 21.5 and 25.9 iu/kg vitamin D3, respectively. Add-
itionally, diets were deficient in linoleic acid (0.18/
0.92 %) as beef tallow was used as the only source of fat
to mimic red meat consumption. The level of phosphorus
was 0.15 and 0.18 % in the low fat and high fat diets, re-
spectively. All other nutrients were met by the NRC re-
quirements for rodents. Diet consumption was registered
cagewise during the last week of the experiment.
Fecal water content
Fresh fecal pellets were collected, weighed and freeze-
dried. Fecal water content was calculated as the weight
difference before and after freeze-drying.
Scoring of lesions
After termination by cervical dislocation, the intestines
were excised and extensively flushed with phosphate-
buffered saline (PBS). Small intestine and colon were cut
open longitudinally, and the small intestine was divided
into three sections (proximal, middle, distal part). All
parts of the intestine were then flattened between to
filter papers. The intestinal preparations were fixed in
10 % neutral buffered formalin overnight and subse-
quently stained (5–10 s) in 0.2 % methylene blue dis-
solved in the formalin solution. After another 24 h in
10 % formalin, the intestines were scored for intestinal
lesions by surface microscopy. The number of lesions
was recorded, and the size of each lesion was calculated
based on the diameter, measured with an eyepiece grati-
cule. The total surface area covered by lesions was
defined as load. The scoring was performed blindly, by
one observer. Stained lesions appeared bright blue in
contrast to the brownish-green surrounding epithelium
(Additional file 1: Figure S1). Colonic lesions were classi-
fied into two categories: flat aberrant crypt foci (flat
Table 1 Study groups and composition of the experimental diets
Hemin− Low fat Hemin+ Low fat Hemin− High fat Hemin+ High fat
N (female/male) 11/14 12/13 10/10 10/10
Metabolisable energy (MJ/kg) 13.79 13.78 16.61 16.61
% as fat 10 % 10 % 40 % 40 %
% as protein 20 % 20 % 20 % 20 %
% as carbo 70 % 70 % 40 % 40 %
Moisture (g/100 g) 4.35 4.35 4.45 4.45
Rice starch (g/100 g) 29.88 29.88 19.9 19.9
Sucrose (g/100 g) 36.11 36.11 25.59 25.59
Crude protein (g/100 g) 18.7 18.7 22.49 22.49
Crude fat (g/100 g) 4.22 4.22 20.39 20.39
Crude fiber (g/100 g) 2 2 2.23 2.23
AIN-93G-MX
(adjusted for Ca and P) (g/100 g)
3.5 3.5 4.18 4.18
AIN-93-VX (w/o Vit D3) (g/100 g) 1 1 1.20 1.20
l-Cystine (g/100 g) 0.323 0.323 0.38 0.38
Choline Bitartrate (g/100 g) 0.24 0.24 0.29 0.29
Hemin (μmol/g) – 0.5 – 0.6
adjusted minerals/vitamins level
Total Ca (%) 0.08 % 0.08 % 0.10 % 0.10 %
Total P (%) 0.15 % 0.15 % 0.18 % 0.18 %
Total Vit D3 (ui/kg) <21.5 <21.5 <25.9 <25.9
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ACF) and tumors. Flat ACF are suggested to be the early
stages of tumors, as both flat ACF and tumors share
morphologic features such as enlarged, compressed
crypt openings, which form gyrus-like pit patterns as they
increase in size. Tumors are defined by a crypt multiplicity
of more than 30 crypts, and commonly show, in contrast to
flat ACF, structures that appear elevated compared to the
surrounding epithelium. In the A/J Min/+ mouse model,
colonic lesions demonstrate continuous development from
flat ACF to tumors [25], therefor merged data for colonic
lesions was used to generate a size distribution graph. For
presentation of the size distribution, lesions were allocated
into the following size classes: 0–0.008 mm2, 0.009–
0.064 mm2, 0.065–0.512 mm2, 0.512–4.096 mm2, and
>4.096 mm2. The size classes are based on a logarith-
mic scale to improve the readability of the graph. The
categories build upon a base-eight logarithm, which al-
lows the smallest lesions (approximately 1–4 crypts) to
be grouped within the first size class.
TBARS
To assess the rate of lipid peroxidation in the lumen,
TBARS were analysed in fecal water. The procedure of
TBARS analysis was adapted from previously described
protocols [31, 32]. Fecal water was prepared from
freeze-dried 24-h feces collected from 1–3 mice. 150 mg
grounded feces was incubated with 1000 μl distilled
water for 60 min at 37 °C. After centrifugation at
20,000×g for 15 min, supernatants were frozen at −20 °C
until use. For the assay, 40 μl of sample was replenished
with 60 μl distilled water and mixed with 100 μl sodium
dodecyl sulphate (8.1 %). After the addition of 1 ml 2-
thiobarbituric acid solution (0.05 % in 10 % acetic acid),
samples were incubated for 75 min at 82 °C. Absorption
spectra (450 to 700 nm) were read using an Epoch
Microplate Spectrophotometer (Biotek, Winooski,
United States) with Gen5TM Microplate Data Analysis
Software. Peak absorption at 532 nm was corrected for
baseline absorbance by subtracting the absorbance at
700 nm. 1,1,3,3,-tetramethoxypropane was used as a
standard (covered range: 0, 25, 50, 100, 200 μM) and
underwent the same procedure as samples. Results are
expressed as μM malondialdehyde equivalents per
millilitre fecal water.
Statistics and data presentation
The distribution of the intestinal lesion parameters was
heavily skewed and could not be transformed to meet
the assumptions of parametric tests. Hence, relationships
between outcome variables and dietary factors (high fat
and hemin) were analyzed using quantile regression.
Due to the low incidence of colonic tumors, a cut-off
point of 75 % was used for tumor number, average size
and load in the colon, and odds ratios were calculated
for tumor incidence. Median regression was used for all
other variables. The relationship between lesions and
fecal parameters was evaluated in the entire data set
and within groups (within Hemin− and Hemin+; within
Low fat and High fat) by determination of the Spearman’s
correlation coefficient. A p-value of p < 0.05 was
considered significant. Figures present results as me-
dian [interquartile range percentile (IQR): percentile
25-percentile 75] and mean. Raw data are provided in
Additional file 2.
Results
Animals and food consumption
After 8 weeks on the experimental diets, body weight
and food consumption were not related to dietary hemin
or fat level (Additional file 2: Table S2).
Effects of hemin and fat on intestinal carcinogenesis
The tumorigenic potential of dietary hemin and fat, as
well as the interaction of the two factors, was tested on
the following variables: number of colonic lesions (flat
ACF and tumors), number of small intestinal tumors,
average lesion size (mm2) and load (total lesion area per
animal). No significant interactions of the dietary inter-
ventions were observed for any of the outcome parame-
ters, thus, the hemin x fat interaction was removed from
all subsequent analyses.
Colon
Independent of the fat level, dietary intervention with
hemin caused a significant decrease in the number of
flat ACF (p = 0.036) (Table 2), as well as the total area
covered by flat ACF (load, p = 0.040) in the colon. As
presented in Fig. 1, the inhibitory effect of hemin was
also apparent for the average size of flat ACF and co-
lonic tumor parameters, albeit statistical significance was
not reached (Table 2). The proportion of mice develop-
ing colonic tumors was significantly decreased by dietary
hemin (odd ratio = 0.40, 95 % CI: [0.16–0.99], p = 0.046).
No relationship could be established between dietary
fat level and formation of flat ACF. Likewise, tumor inci-
dence (odd ratio 1.0, 95 % CI: [0.44–2.51], p = 0.92),
tumor number and tumor load were not significantly af-
fected by dietary fat level. The growth of colonic tumors,
however, was enhanced by high fat diets and led to a sig-
nificantly increased average tumor size (p = 0.002). Fig. 1b
indicates that also the average size of flat ACF may be
equally affected.
The size distribution of colonic lesions (Fig. 2a) builds
upon the merged data from flat ACF and tumors, as a
transition of flat ACF to tumors can be assumed [25]. The
graph further illustrates the presented results: while only
minor differences can be observed between the low and
high fat diets, mice fed diets devoid of hemin exhibited a
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greater amount of lesions across all size categories than
mice fed hemin-enriched diets.
Small intestine
The number of tumors, average tumor size and tumor
load in the small intestine was found to be independent
of dietary hemin (Fig. 3). High dietary fat content signifi-
cantly enhanced carcinogenesis (Table 2), reflected by a
significant increase in average tumor size (p < 0.001) and
tumor load (p < 0.031). Tumor number tended to be in-
creased by dietary fat, although not significant (Fig. 1a).
The size distribution of the small intestinal tumors
Table 2 Relationship between dietary interventions (hemin and fat) and outcome variables in A/J Min/+ mice
Hemin+ vs. Hemin− High fat vs. low fat
Coefficient p-value Coefficient p-value
Colon
Flat ACF Number per animal −13.0 [−25.1– −0.9] 0.036 5.0 [−7.2–17.2] 0.421
Average Size −0.000 [−0.003–0.002] 0.862 0.002 [−0.001–0.004] 0.142
Load −0.18 [−0.35– −0.01] 0.040 0.14 [−0.03–0.31] 0.105
Tumor Number per animal −1.0 [−4.0–2.0] 0.513 1.0 [−2.0─4.0] 0.515
Average Size −0.28 [−0.67–0.13] 0.181 0.66 [0.23–1.07] 0.002
Load −0.55 [−3.60–2.50] 0.723 1.39 [−1.69–4.46] 0.377
Small intestine
Tumor Number per animal 2.0 [−5.2–9.2] 0.588 6.0 [−1.3–13.3] 0.107
Average Size 0.00 [−0.06–0.58] 1.000 0.12 [0.07–0.18] <0.001
Load 1.13 [−2.52–4.78] 0.544 5.54 [1.86–9.21] 0.031
Fecal Parameters
TBARS 7.1 [3.8–10.4] <0.001 5.3 [1.9–8.6] 0.002
Fecal water content 4.5 [1.9–7.0] 0.001 −2.7 [−5.2– −0.1] 0.045
Regression coefficients [95 % confidence interval] from quantile regression are presented. Significant results (p < 0.05) are shown in bold text
Fig. 1 Development of intestinal lesions in the colon of A/J Min/+ mice. a–c shows data for flat ACF, while d–f represents data for colonic tumors. a
and d number of lesions, b and e average size of lesions, c and f load of lesions. Values are presented as median [IQR] and mean. Dots indicate means
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Fig. 2 Size distribution of intestinal lesions in A/J Min/+ mice. a colon: flat ACF and tumors, b small intestine: tumors
Fig. 3 Development of intestinal lesions in the small intestine of A/J Min/+ mice. a Number of tumors, b average tumor size, c tumor load.
Values are presented as median [IQR] and mean. Dots indicate means
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(Fig. 2b) clearly illustrates how elevated dietary fat
caused a shift towards larger tumor classes (low fat vs.
high fat, 1.3 fold increase in average tumor size).
Effects of hemin and fat on fecal parameters
TBARS
Analysis of fecal water showed that dietary hemin caused
an increase in fecal TBARS concentration (p < 0.001)
(Table 2, Fig. 4a). Furthermore, a significantly higher
TBARS yield was observed in response to high fat diets
than to low fat diets (p = 0.002).
To identify possible relationships between intestinal
carcinogenesis and fecal parameters, Spearman’s rank
correlation coefficients were determined (Table 3). No
association was found between fecal TBARS concentra-
tion and colonic carcinogenesis. In the small intestine, in
contrast, fecal TBARS concentration was positively
linked to the number, average size, and load of the
tumors (Table 3). These correlation data were then
grouped by hemin level to explore the possible influence
of variations of dietary fat, and subsequently by fat level
to explore the possible influence of variations of hemin
level. Significant correlation persisted only in the groups
with varying levels of dietary fat. Figure 5 illustrates how
a significant relationship between small intestinal aver-
age tumor size and TBARS concentration was seen in
animals grouped by hemin level (fat level varied) and
not in animals grouped by fat level (hemin level varied).
This is consistent with the observation that dietary
hemin increased TBARS concentration but did not
affect small intestinal carcinogenesis.
Fecal water content
Fecal water content has previously been related to co-
lonic reabsorption capacity [27]. At the end of the inter-
vention, water content of feces was decreased by high fat
diets (p = 0.045) (Fig. 4b). In contrary, dietary hemin in-
creased water content in feces (p = 0.001). Fecal water
content was not associated with intestinal tumorigenesis
(Additional file 3: Table S3).
Discussion
In the present study we examined the effect of dietary
heme iron on intestinal carcinogenesis and fecal water
concentration of TBARS, a biomarker of lipid peroxida-
tion, in A/J Min/+ mice fed a low or high fat diet.
Although contradicting the current prevailing opinion
regarding hemin and CRC, this work did confirm the
results of a recent study by our group [26]. Instead of
the expected promoting effect [12], heme iron was
found to inhibit carcinogenesis in the colon of A/J
Min/+ mice. While the growth of colonic lesions
remained unaffected, dietary hemin apparently reduced
tumor initiation by decreasing the number of flat ACF,
which represent newly formed colonic lesions.
In our recent study [26], we speculated whether the
lack of a stimulatory response of dietary heme iron was
related to the low level of fat in the diet (4 %) and that
the conditions were insufficient for lipid peroxidation
and cytotoxic heme factor (CHF) formation. Therefore,
the dietary fat level was included as a variable in the
present study. Although high dietary fat content in-
creased colonic tumor growth, the results clearly showed
that changes in dietary fat level were not capable of re-
versing or changing the inhibitory effect of dietary heme
iron on colonic carcinogenesis.
In contrast to what was observed in the colon, dietary
hemin exposure did not influence carcinogenesis in the
small intestine. In hemoglobin-fed C57BL/6 J Min/+
mice, Bastide et al. [33] observed a significant increase
in the number of jejunal tumors and a greater number
of tumors with increased diameter (>1 mm2) along the
entire small intestine. In A/J Min/+ mice, we recently
found an increase in small intestinal tumor size in re-
sponse to dietary heme [26]. It is not clear why no effect
of heme on small intestinal carcinogenesis was observed
in the present study. As in the colon, high dietary fat
Fig. 4 Analysis of feces: a TBARS (μmol/l) in fecal water and b fecal water content. Results are shown as median [IQR] and mean. Dots indicate means
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induced a significant stimulation of carcinogenesis in the
small intestine.
The hypothesis of a contribution of lipid peroxides to the
carcinogenesis of colorectal cancer is widely supported in
the literature [5, 10]. In the present study, however, correl-
ation analysis revealed no indication that fecal TBARS are
related to colonic carcinogenesis. Although a correlation
was found between TBARS and small intestinal tumors,
the observed association was dependent on varying dietary
fat level and was not verifiable when investigated within the
high and low fat groups separately. Despite the enhanced
concentration of fecal TBARS following the ingestion of
dietary heme iron, hemin did not affect small intestinal
carcinogenesis, and even inhibited carcinogenesis in the
colon. An increased TBARS concentration in fecal water
has previously been linked to heme-induced cell prolifera-
tion [12], and when calcium phosphate was added to a
beef-based diet, a decrease in the promotion of colonic
lesions was accompanied by a reduced level of TBARS and
cytotoxicity of fecal water [15]. In contrast, however,
Santarelli et al. [34] did not find an association between the
level of peroxidation and the promotion of colonic lesions,
and despite an elevated concentration of TBARS, Martin et
al. [35] also did not observe a change in cell proliferation in
response to dietary hemoglobin. Levels of malondialdehyde
(as TBARS) and 4-hydroxynonenal, two conventional bio-
markers for lipid peroxidation, are tightly related to the fat
source used in experimental diets [36, 37]. Therefore it may
be difficult to make predictions about the carcinogenic po-
tential of experimental diets based on these particular per-
oxidation products. Further studies are needed to define
the role of individual peroxidation products in the carcino-
genesis of colorectal cancer, but based on the present re-
sults, the heme-induced formation of TBARS appears to
occur as an independent event within the carcinogenesis in
the colon. The relevance of fecal TBARS as a biomarker for
colorectal cancer development is further questioned, as
Bastide et al. [33] did not find any cytotoxic or genotoxic
effects of malondialdehyde, the most prevalent TBARS, on
cultured Apc+/+ and Apc+/− cells in vitro.
In the present study, carcinogenesis in both the colon
as well as the small intestine was enhanced when the
Table 3 Correlation between fecal TBARS and small intestinal lesions
Number of lesions Average lesion size Lesion load
ρ p-value ρ p-value ρ p-value
Colon, flat ACF
Total −0.079 0.477 0.039 0.724 −0.084 0.446
Colon, tumor
Total −0.132 0.233 −0.098 0.377 −0.109 0.324
Small intestine, tumor
Total 0.227 0.038 0.286 0.008 0.265 0.015
Within Hemin− 0.354 0.025 0.422 0.007 0.374 0.018
Within Hemin+ 0.213 0.165 0.329 0.029 0.286 0.060
Within Low fat 0.178 0.242 0.232 0.126 0.243 0.108
Within High fat 0.002 0.991 0.031 0.853 −0.049 0.768
ρ, Spearman’s rank correlation coefficient. Significant results from Spearman’s ρ (p < 0.05) are shown in bold text
Fig. 5 Relationship between average tumor size in the small intestine and fecal TBARS. A 95 % bivariate normal density ellipse and p-values from
Spearman’s ρ are shown to reflect the degree of correlation within the a Hemin− and Hemin+ group, and b Low fat and High fat group
Steppeler et al. BMC Cancer  (2016) 16:832 Page 8 of 11
level of fat in the diet was increased. The fatty acid com-
position of the experimental diets was designed to reflect
consumption of red meat, and beef tallow was used as
the only fat source. Animal fat from red meat mainly
consists of saturated fat, omega-6 polyunsaturated fatty
acids (n-6 PUFAs) and cholesterol. Beside its susceptibly
to oxidative processes, it is still under debate how fat
level and fatty acid composition of the diet may affect
CRC. High levels of fat have been shown to stimulate
the secretion of bile acids, which can be harmful to the
intestine after being metabolized by microbiota in the
gut [38, 39]. Additionally, n-6 PUFAs can modulate the
immune response after being subjected to enzymatic
conversion and being further metabolized into eicosa-
noids with mainly pro-inflammatory properties [40]. Al-
though a high dietary fat content is associated with
increased tumor formation in various animal studies
[41–45], the link is generally not supported by epidemio-
logical evidence [46, 47].
The percentage of dietary linoleic acid (C18:2, n-6) in
the current study, as well as the estimated percentage of
linoleic acid provided by soybean oil in our recent study
[26] was below the concentration of the safflower oil
based diets used by Pierre and colleagues [32], or the
mixture of corn and palm oil commonly used by van der
Meer and colleagues [48]. Hence, it cannot be excluded,
that the formation of a CHF, as proposed by Ijssennag-
ger et al. [12] is dependent on a critical level of n-6 fatty
acids or specific PUFAs. However, in a long term study
by Winter et al. [49], dietary heme tended to decrease
the incidence of colonic neoplasms in mice, despite a
high level of linoleic acid, provided by sunflower oil
(16.8 g/100 g diet).
Fecal water content and content of cations have previ-
ously been used as parameters for the colonic reabsorp-
tion capacity [27]. Fecal cation content in rat feces was
shown to increase in response to heme, and was linked
to the degree of colonic epithelial damage [27, 50]. In
the present study, however, increased fecal moisture in
response to hemin was not associated with carcinogen-
esis, which may indicate that the colonic epithelium was
not severely damaged. These contradicting findings may
be the result of other underlying factors that have the
ability to modulate fecal water content, such as the rich-
ness and composition of microbiota. For instance, the
Bacteroidetes: Firmicutes ratio which was previously
found to be increased by dietary heme [51], is positively
correlated with stool consistency in humans [52].
We have tested the effects of dietary heme by exposing
A/J Min/+ mice from 3 to week 11 of age, a period where
the majority of flat ACF are formed spontaneously [25].
This window of exposure was also chosen based on the idea
that young mice, in particular, may be highly susceptible to
stimuli that may enhance colon carcinogenesis. This has
previously been demonstrated in young Min/+ mice treated
with the colon carcinogen azoxymethane (AOM) [28, 53].
Although dietary hemin appeared to be protective in mice
at this early stage of life, we cannot rule out potential
stimulatory effects of long time exposure. Long-term stud-
ies are required to investigate the effect of exposure during
periods of tumor progression in old mice [25].
Conclusions
When testing the dietary heme hypothesis in the A/J
Min/+ mouse model, we found that dietary hemin
inhibited colonic carcinogenesis and enhanced fecal
TBARS concentration independent of dietary fat level.
Small intestinal carcinogenesis was not affected by hemin.
High dietary fat stimulated intestinal tumor growth as well
as increased TBARS concentration. Further research is
needed to clarify the role of lipid peroxidation during
intestinal carcinogenesis, and whether interactions between
heme iron and other dietary compounds may be respon-
sible for the link between red meat and CRC observed in
epidemiological studies.
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